NeuroSky, a US-based developer of biosensors for computer games and other electronic products, has raised $11.8m in its series C round from four Asian strategic investors. Taiwan-based computer manufacturer Micro-Star International’s corporate venturing unit, Taicom Capital, led the C round.
Taicom was joined by Taiwan-based peer Yuen Foong Yu Paper Manufacturing’s $68.2m Taiwan Global BioFund; Japan-based industrial services conglomerate Marubeni; and computer services company TUVC. Investment bank WR Hambrecht also participated in the C round, having invested alongside Murabeni and TUVC in NeuroSky’s two previous rounds worth an aggregate $7m since the company’s launch in 2004.
Joining Neurosky’s board are Chris Wei, president of Taicom Capital, and Hong Jen Chang, chief executive of Taiwan Global BioFund and the former deputy minister of health in Taiwan.
Stanley Yang, chief executive of NeuroSky, was reported by VentureWire as saying: ""The technology is in its infancy, and we’re making that charge. The vision is to have biosensors everywhere five to 10 years from now. It’s a transition in everyday life from humans conforming to machines, to machines conforming to humans. That’s what biosensing is all about."